Comprehensive behavioral analysis of pituitary adenylate cyclase-activating polypeptide (PACAP) knockout mice

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide acting as a neurotransmitter, neuromodulator, or neurotrophic factor. PACAP is widely expressed throughout the brain and exerts its functions through the PACAP-specific receptor (PAC1). Recent studies reveal that genetic variants of the PACAP and PAC1 genes are associated with mental disorders, and several behavioral abnormalities of PACAP knockout (KO) mice are reported. However, an insufficient number of backcrosses was made using PACAP KO mice on the C57BL/6J background due to their postnatal mortality. To elucidate the effects of PACAP on neuropsychiatric function, the PACAP gene was knocked out in F1 hybrid mice (C57BL/6J × 129SvEv) for appropriate control of the genetic background. The PACAP KO mice were then subjected to a behavioral test battery. PACAP deficiency had no significant effects on neurological screen. As shown previously, the mice exhibited significantly increased locomotor activity in a novel environment and abnormal anxiety-like behavior, while no obvious differences between genotypes were shown in home cage (HC) activity. In contrast to previous reports, the PACAP KO mice showed normal prepulse inhibition (PPI) and slightly decreased depression-like behavior. Previous study demonstrates that the social interaction (SI) in a resident-intruder test was decreased in PACAP KO mice. On the other hand, we showed that PACAP KO mice exhibited increased SI in Crawley's three-chamber social approach test, although PACAP KO had no significant impact on SI in a HC. PACAP KO mice also exhibited mild performance deficit in working memory in an eight-arm radial maze (RM) and the T-maze (TM), while they did not show any significant abnormalities in the left-right discrimination task in the TM. These results suggest that PACAP has an important role in the regulation of locomotor activity, social behavior, anxiety-like behavior and, potentially, working memory.

[1]  Jan Fawcett,et al.  THE IMPORTANCE OF ANXIETY IN BOTH MAJOR DEPRESSION AND BIPOLAR DISORDER , 2012, Depression and anxiety.

[2]  Keizo Takao,et al.  T-maze Forced Alternation and Left-right Discrimination Tasks for Assessing Working and Reference Memory in Mice , 2012, Journal of visualized experiments : JoVE.

[3]  D. Reglodi,et al.  The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger–Westphal nucleus, ventral lateral septum, and dorsal raphe n , 2012, Neuroscience.

[4]  J. Sebat,et al.  Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia , 2011, Nature.

[5]  L. Eiden,et al.  PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response , 2011, Annals of the New York Academy of Sciences.

[6]  J. Sebat,et al.  Duplications of the Neuropeptide Receptor VIPR2 Confer Significant Risk for Schizophrenia , 2011, Nature.

[7]  B. Bradley,et al.  Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor , 2011, Nature.

[8]  H. Hashimoto,et al.  Environmental factors during early developmental period influence psychobehavioral abnormalities in adult PACAP-deficient mice , 2010, Behavioural Brain Research.

[9]  W. Falls,et al.  Roles for Pituitary Adenylate Cyclase-Activating Peptide (PACAP) Expression and Signaling in the Bed Nucleus of the Stria Terminalis (BNST) in Mediating the Behavioral Consequences of Chronic Stress , 2010, Journal of Molecular Neuroscience.

[10]  M. Itokawa,et al.  Replication study of association between ADCYAP1 gene polymorphisms and schizophrenia , 2010, Psychiatric genetics.

[11]  T. Miyakawa,et al.  Behavioral profiles of three C57BL/6 substrains , 2010, Neuroscience Research.

[12]  O. Saitoh,et al.  Possible association between the pituitary adenylate cyclase-activating polypeptide (PACAP) gene and major depressive disorder , 2010, Neuroscience Letters.

[13]  R. Hashimoto,et al.  Depression‐like behavior in the forced swimming test in PACAP‐deficient mice: amelioration by the atypical antipsychotic risperidone , 2009, Journal of neurochemistry.

[14]  W. Falls,et al.  Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): Roles for PACAP in anxiety-like behavior , 2009, Psychoneuroendocrinology.

[15]  Keizo Takao,et al.  Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice , 2009, Molecular Brain.

[16]  K. Fukunaga,et al.  Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders , 2008, European Psychiatry.

[17]  T. Miyakawa,et al.  Elevated Plus Maze for Mice , 2008, Journal of visualized experiments : JoVE.

[18]  T. Miyakawa,et al.  Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia , 2008, Molecular Brain.

[19]  W. Berrettini,et al.  Association analysis of the pituitary adenylate cyclase-activating polypeptide (PACAP/ADCYAP1) gene in bipolar disorder , 2008, Psychiatric genetics.

[20]  T. Miyakawa.  Impact of brain-behavior phenotypying of genetically engineered mice on research of neuropsychiatric disorders , 2007, Neuroscience Research.

[21]  D. Weinberger,et al.  Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia , 2007, Molecular Psychiatry.

[22]  T. Miyakawa,et al.  Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders , 2007, Neuroscience Research.

[23]  P. Gressens,et al.  The Neuropeptide Pituitary Adenylate Cyclase‐Activating Polypeptide Exerts Anti‐Apoptotic and Differentiating Effects during Neurogenesis: Focus on Cerebellar Granule Neurones and Embryonic Stem Cells , 2007, Journal of neuroendocrinology.

[24]  服部 剛志.  A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein : implication in the modulation of DISC1-dependent neurite outgrowth , 2007 .

[25]  E. Sariban,et al.  The neuropeptide pituitary adenylate cyclase activating protein stimulates human monocytes by transactivation of the Trk/NGF pathway. , 2007, Cellular signalling.

[26]  T. Miyakawa,et al.  Light/dark Transition Test for Mice , 2006, Journal of visualized experiments : JoVE.

[27]  T. Miyakawa,et al.  Investigating Gene‐to‐Behavior Pathways in Psychiatric Disorders , 2006, Annals of the New York Academy of Sciences.

[28]  H. Hashimoto,et al.  New Insights into the Central PACAPergic System from the Phenotypes in PACAP‐ and PACAP Receptor‐Knockout Mice , 2006, Annals of the New York Academy of Sciences.

[29]  C. Gillberg,et al.  The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. , 2006, The American journal of psychiatry.

[30]  T. Miyakawa,et al.  Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder? , 2006, Biological Psychiatry.

[31]  D. Weinberger,et al.  Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models , 2006, Biological Psychiatry.

[32]  R. Hashimoto,et al.  Psychostimulant-Induced Attenuation of Hyperactivity and Prepulse Inhibition Deficits in Adcyap1-Deficient Mice , 2006, The Journal of Neuroscience.

[33]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[34]  J. Crawley.  Designing mouse behavioral tasks relevant to autistic-like behaviors. , 2004, Mental retardation and developmental disabilities research reviews.

[35]  T. Otto,et al.  Altered Social Behavior in Pituitary Adenylate Cyclase-Activating Polypeptide Type I Receptor-Deficient Mice , 2004, The Journal of Neuroscience.

[36]  J. Piven,et al.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice , 2004, Genes, brain, and behavior.

[37]  Wim E Crusio.  Flanking gene and genetic background problems in genetically manipulated mice , 2004, Biological Psychiatry.

[38]  H. Hashimoto,et al.  Functional roles of the neuropeptide PACAP in brain and pancreas. , 2003, Life sciences.

[39]  Hongkui Zeng,et al.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Avner,et al.  Congenic mice: cutting tools for complex immune disorders , 2003, Nature Reviews Immunology.

[41]  J. Coyle,et al.  Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.

[42]  F. Castellanos,et al.  Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes , 2002, Nature Reviews Neuroscience.

[43]  W. Young,et al.  Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Miyazaki,et al.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  F. Jirik,et al.  Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. , 2001, Molecular endocrinology.

[46]  J. Molina,et al.  Fine-scale mapping of a locus for severe bipolar mood disorder on chromosome 18p11.3 in the Costa Rican population , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Maldonado,et al.  Altered emotional behavior in PACAP-type-I-receptor-deficient mice. , 2001, Brain research. Molecular brain research.

[48]  A. Konnerth,et al.  Impairment of Mossy Fiber Long-Term Potentiation and Associative Learning in Pituitary Adenylate Cyclase Activating Polypeptide Type I Receptor-Deficient Mice , 2001, The Journal of Neuroscience.

[49]  F. Jamen,et al.  Dissociation between Light-Induced Phase Shift of the Circadian Rhythm and Clock Gene Expression in Mice Lacking the Pituitary Adenylate Cyclase Activating Polypeptide Type 1 Receptor , 2001, The Journal of Neuroscience.

[50]  P. Bebbington,et al.  Anxiety and the schizophrenic process: clinical and epidemiological evidence , 2001, Social Psychiatry and Psychiatric Epidemiology.

[51]  Y. Okubo,et al.  Association analysis of the pituitary adenyl cyclase activating peptide gene (PACAP) on chromosome 18p11 with schizophrenia and bipolar disorders , 2001, Journal of Neural Transmission.

[52]  F. Holsboer,et al.  Mild deficits in mice lacking pituitary adenylate cyclase-activating polypeptide receptor type 1 (PAC1) performing on memory tasks. , 2000, Brain research. Molecular brain research.

[53]  A. Holmes,et al.  Behavioral profile of wild mice in the elevated plus-maze test for anxiety , 2000, Physiology & Behavior.

[54]  H. Vaudry,et al.  Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. , 2000, Pharmacological reviews.

[55]  J. Crabbe,et al.  Genetics of mouse behavior: interactions with laboratory environment. , 1999, Science.

[56]  A. Arimura.  Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. , 1998, The Japanese journal of physiology.

[57]  Hee-Sup Shin,et al.  Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background , 1997, Neuron.

[58]  Allan Collins,et al.  Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies , 1997, Psychopharmacology.

[59]  R. Gerlai.  Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? , 1996, Trends in Neurosciences.

[60]  J. Crawley,et al.  Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. Olton,et al.  Memory impairments following basal forebrain lesions , 1985, Brain Research.

[62]  J. Crawley.  Exploratory behavior models of anxiety in mice , 1985, Neuroscience & Biobehavioral Reviews.

[63]  B. Bradley,et al.  Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor , 2011, Nature.